Amneal Pharmaceuticals, Inc. (AMRX)
14.92
+0.29
(+1.98%)
USD |
NASDAQ |
Feb 13, 11:14
Amneal Pharmaceuticals Free Cash Flow : 236.43M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Corcept Therapeutics, Inc. | 162.57M |
| Pfizer Inc. | 10.38B |
| Apellis Pharmaceuticals, Inc. | 78.64M |
| Nektar Therapeutics | -190.35M |
| Innoviva, Inc. | 196.54M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 118.45M |
| Cash from Investing (Quarterly) | -22.46M |
| Cash from Financing (Quarterly) | 59.44M |
| Free Cash Flow Per Share (Quarterly) | 0.2956 |
| Free Cash Flow to Equity (Quarterly) | -7.845M |
| Free Cash Flow to Firm (Quarterly) | -122.08M |
| Free Cash Flow Yield | 4.95% |